β-Lactamases: Which ones are clinically important?

Drug Resistance Updates

Volumn 3, Issue 3, 2000, Pages 178-189

  Rice, Louis B ^a   Bonomo, Robert A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PENICILLINASE; SULBACTAM; TAZOBACTAM;

BACTERIAL INFECTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033862706     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0144     Document Type: Article

References (91)

1. Beta-lactamase-mediated resistance
2. A functional classification scheme for β-lactamases and its correlation with molecular structure
3. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
4. The structure of β-lactamases
5. Nosocomial bloodstream infections in United States hospitals: A three year analysis
6. Two improved promoter sequences for the β-lactamase expression arising from a single base-pair substitution
7. R plasmid and gene dosage effects in Escherichia coli K-12: Copy mutants of the R plasmid R1 drd-19
8. Hyperproduction of TEM-1 β-lactamase in clinical isolates of Escherichia coli serotype O15
9. Transferable hyperproduction of TEM-1 β-lactamase in Shigella flexneri due to a point mutation in the Pribnow box
10. The nature of the genetic determinant for the SHV-1 β-lactamase
11. Complete amino acid sequence of p453-plasmid-mediated PIT-2 β-lactamase (SHV-1)
12. Close evolutionary relationship between the chromosomally encoded β-lactamase gene of Klebsiella pneumoniae and the TEM β-lactamase gene mediated by R plasmids
13. Rarity of transferable β-lactamase production by Klebsiella species
14. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae
15. Molecular characterization of a new plasmid-encoded SHV-type β-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae
16. Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy
17. Structure of the SHV-1 β-lactamase
18. More extended-spectrum β-lactamases
19. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
20. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility
21. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
22. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases
23. Piperacillin, tazobactam, and gentamicin alone or in combination in an endocarditis model of infection by a TEM-3 producing strain of Klebsiella pneumoniae or its susceptible variant
24. Efficacy of different β-lactams against an extended spectrum β-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model
25. In vivo efficacies of β-lactam-β-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae
26. A clavulanate resistant mutant of the TEM β-lactamase (R244S) is suppressed intracistronically to clavulanate sensitivity by a second mutation (R164S) that produces ceftazidime resistance
27. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 β-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime
28. Tazobactam is a potent inhibitor of select class A inhibitor-resistant enzymes
29. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 β-lactamase
30. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins
31. Characterization of four β-lactamases produced by Staphylococcus aureus
32. Penicillinase plasmids of Staphylococcus aureus: Structural and evolutionary relationships
33. Characterization of the staphylococcal β-lactamase transposon Tn552
34. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus
35. blal and blaRl regulate β-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus
36. Nature and interactions of the genetic elements governing penicillinase synthesis in Staphylococcus aureus
37. Studies of the repressor (Blal) of beta-lactarnase synthesis in Staphylococcus aureus
38. Proteolytic cleavage of the repressor (Blal) of beta-lactamase synthesis in Staphylococcus aureus
39. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections
40. Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection
41. Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases
42. Molecular characterization of the β-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. Medical Centers during 1994-1995 and 1997-1998
43. Susceptibilities of 394 Bacteroides fragilis, non-B, fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents
44. Genetic and biochemical analysis of a novel Ambler class A β-lactamase responsible for cefoxitin resistance in Bacteroides species
45. A survey of the kinetic parameters of class C β-lactamases: Penicillins
46. A survey of the kinetic parameters of class C β-lactamases: Cephalosporins and other β-lactam compounds
47. Evolution of an enzyme activity: Crystallographic structure at 2 Å resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a Class A penicillinase
48. Refined crystal structure of β-lactamase from Citrobacter freundii indicates a mechanism for β-lactam hydrolysis
49. Structure of the extended-spectrum class C b-lactamase of Enterobacter cloacae GCI, a natural mutant with a tandem tripeptide insertion
50. Three-dimensional structure of AmpC β-lactamase from Escherichia coli bound to a transition-state analogue: Possible implications for the oxyanion hypothesis and for inhibitor design
51. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in gram-negative bacteria
52. Induction of β-lactamase in Enterobacter cloacae
53. Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae
54. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction
55. The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide
56. AmpD, essential for both β-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase
57. System atNNIS. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States
58. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae
59. Sequence of the MIR-1 beta-lactamase gene
60. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance
61. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes
62. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2)
63. Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis
64. Characterization of the plasmid mediated beta-lactamase BIL-1
65. Cloning and sequence analysis of bla(BIL)-l, a plasmid-mediated class C β-lactamase gene in Escherichia coli BS
66. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii
67. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type β-lactamase: Confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC β-lactamase
68. A novel type of AmpC βa-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia
69. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
70. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein
71. Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa
72. Carbapenem-hydrolyzing beta-lactamases
73. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: A new molecular class B β-lactamase showing a broad substrate profile
74. The 3-D structure of a zinc metallo-β-lactamase from Bacillus cereus reveals a new type of protein fold
75. Crystal structure of the wide-spectrum binuclear zinc βa-lactamase from Bacteroides fragilis
76. Crystal structure of the IMP-1 metallo β-Lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: Binding determinants of a potent, broad-spectrum inhibitor
77. The crystal structure of the LI metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution
78. The diversity, structure and regulation of beta-lactamases
79. Cryoenzymology of Bacillus cereus β-lactamase II
80. Kinetic mechanism of metallo-β-lactamase L1 from Stenotrophomonas maltophilia
81. Expression of the AsbAl, OXA-12, and AsbMl β-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon
82. A novel integron-like element carrying the metallo-beta-lactamase gene blalMP
83. Structure of In31, a blalMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes
84. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance
85. PCR detection of metallo-β-lactamase gene (blalMP) in gram-negative rods resistant to broad-spectrum β-lactams
86. Novel metallo β-lactamase mediated by a Shigella flexneri plasmid
87. Antimicrobial resistance in Bacteroides
88. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
89. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
90. Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases
91. The first structural and mechanistic insights for class D β-lactamases: Evidence for a novel catalytic process for turnover of β-lactam antibiotics